Establishment of a new predictive model for the recurrence of upper urinary tract stones.
Indicators
Model
Nomogram
Recurrence
Upper urinary tract stones
Journal
International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
24
04
2023
accepted:
30
06
2023
medline:
14
9
2023
pubmed:
12
7
2023
entrez:
12
7
2023
Statut:
ppublish
Résumé
To construct a nomogram for evaluation of the recurrence risk of upper urinary tract stones in patients. We retrospectively reviewed the clinical data of 657 patients with upper urinary tract stones and divided them into stone recurrence group and non-recurrence group. Blood routine, urine routine, biochemical, and urological CT examinations were searched from the electronic medical record, relevant clinical data were collected, including age, BMI, stones number and location, maximum diameter, hyperglycemia, hypertension, and relevant blood and urine parameters. The Wilcoxon rank-sum test, independent sample t test, and Chi-square test were used to preliminarily analyze the data of the two groups, then LASSO and logistic regression analysis were used to find out the significant difference indicators. Finally, R software was used to draw a nomogram to construct the model, and ROC curve was drawn to evaluate the sensitivity and specificity. The results showed that multiple stones (OR: 1.832, 95% CI 1.240-2.706), bilateral stones (OR: 1.779, 95% CI 1.226-2.582), kidney stones (OR: 3.268, 95% CI 1.638-6.518), and kidney ureteral stones (OR: 3.375, 95% CI 1.649-6.906) were high risk factors. And the stone recurrence risk was positively correlated with creatinine (OR: 1.012, 95% CI 1.006-1.018), urine pH (OR: 1.967, 95% CI 1.343-2.883), Apo B (OR: 4.189, 95% CI 1.985-8.841) and negatively correlated with serum phosphorus (OR: 0.282, 95% CI 0.109-0.728). In addition, the sensitivity and specificity of the prediction model were 73.08% and 61.25%, diagnosis values were greater than any single variable. The nomogram model can effectively evaluate the recurrence risk of upper urinary stones, especially suitable for stone postoperative patients, to help reduce the possibility of postoperative stone recurrence.
Identifiants
pubmed: 37436572
doi: 10.1007/s11255-023-03698-8
pii: 10.1007/s11255-023-03698-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2411-2420Subventions
Organisme : National Natural Science Foundation of China
ID : 82070724
Organisme : Natural Science Foundation of Anhui Province
ID : 1908085MH246
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Tzelves L, Türk C, Skolarikos A (2021) European association of urology urolithiasis guidelines: where are we going? Eur Urol Focus. https://doi.org/10.1016/j.euf.2020.09.011
doi: 10.1016/j.euf.2020.09.011
pubmed: 34848163
Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, Long Y, Ma J, Li Y, Wan SP, Wu W, Liu Y, Cui Z, Zhao Z, Qin J, Zeng T, Liu Y, Duan X, Mai X, Yang Z, Kong Z, Zhang T, Cai C, Shao Y, Yue Z, Li S, Ding J, Tang S, Ye Z (2017) Prevalence of kidney stones in china: an ultrasonography based cross-sectional study. BJU Int. https://doi.org/10.1111/bju.13828
doi: 10.1111/bju.13828
pubmed: 28692204
Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y (2017) Epidemiology of stone disease across the world. World J Urol. https://doi.org/10.1007/s00345-017-2008-6
doi: 10.1007/s00345-017-2008-6
pubmed: 28255621
Milligan M, Berent AC (2019) Medical and interventional management of upper urinary tract uroliths. Vet Clin North Ame. https://doi.org/10.1016/j.cvsm.2018.11.004
doi: 10.1016/j.cvsm.2018.11.004
Ziemba JB, Matlaga BR (2017) Epidemiology and economics of nephrolithiasis. Investig Clin Urol. https://doi.org/10.4111/icu.2017.58.5.299
doi: 10.4111/icu.2017.58.5.299
pubmed: 28868500
pmcid: 5577325
Antonelli JA, Maalouf NM, Pearle MS, Lotan Y (2014) Use of the national health and nutrition examination survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol 66(4):724–729. https://doi.org/10.1016/j.eururo.2014.06.036
doi: 10.1016/j.eururo.2014.06.036
pubmed: 25015037
pmcid: 4227394
Ingvarsdottir SE, Indridason OS, Palsson R, Edvardsson VO (2020) Stone recurrence among childhood kidney stone formers: results of a nationwide study in iceland. Urolithiasis. https://doi.org/10.1007/s00240-020-01179-6
doi: 10.1007/s00240-020-01179-6
pubmed: 32107578
Wang Z, Zhang Y, Zhang J, Deng Q, Liang H (2021) Recent advances on the mechanisms of kidney stone formation (review). Int J Mol Med. https://doi.org/10.3892/ijmm.2021.4982
doi: 10.3892/ijmm.2021.4982
pubmed: 34935058
pmcid: 8711589
Daudon M, Jungers P, Bazin D, Williams JC (2018) Recurrence rates of urinary calculi according to stone composition and morphology. Urolithiasis. https://doi.org/10.1007/s00240-018-1043-0
doi: 10.1007/s00240-018-1043-0
pubmed: 29869684
pmcid: 6711148
Daudon M, Dessombz A, Frochot V, Letavernier E, Haymann J, Jungers P, Bazin D (2016) Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrolithiasis. C R Chim. https://doi.org/10.1016/j.crci.2016.05.008
doi: 10.1016/j.crci.2016.05.008
Baowaidan F, Zugail AS, Lyoubi Y, Culty T, Lebdai S, Brassart E, Bigot P (2022) Incidence and risk factors for urolithiasis recurrence after endourological management of kidney stones: a retrospective single-centre study. Prog Urol. https://doi.org/10.1016/j.purol.2022.02.010
doi: 10.1016/j.purol.2022.02.010
pubmed: 35314101
Ding Q, Ouyang J, Fan B, Cao C, Fan Z, Ding L, Li F, Tu W, Jin X, Wang J, Shi Y (2019) Association between dyslipidemia and nephrolithiasis risk in a chinese population. Urol Int. https://doi.org/10.1159/000496208
doi: 10.1159/000496208
pubmed: 30673680
Otto BJ, Bozorgmehri S, Kuo J, Canales M, Bird VG, Canales B (2017) Age, body mass index, and gender predict 24-hour urine parameters in recurrent idiopathic calcium oxalate stone formers. J Endourol. https://doi.org/10.1089/end.2017.0352
doi: 10.1089/end.2017.0352
pubmed: 29084490
Wang K, Ge J, Han W, Wang D, Zhao Y, Shen Y, Chen J, Chen D, Wu J, Shen N, Zhu S, Xue B, Xu X (2022) Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urol. https://doi.org/10.1186/s12894-022-01017-4
doi: 10.1186/s12894-022-01017-4
pubmed: 36566200
pmcid: 9789644
Thongprayoon C, Krambeck AE, Rule AD (2020) Determining the true burden of kidney stone disease. Nat Rev Nephrol. https://doi.org/10.1038/s41581-020-0320-7
doi: 10.1038/s41581-020-0320-7
pubmed: 32753740
Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, Türk C (2015) Metabolic evaluation and recurrence prevention for urinary stone patients: eau guidelines. Eur Urol. https://doi.org/10.1016/j.eururo.2014.10.029
doi: 10.1016/j.eururo.2014.10.029
pubmed: 26344917
Tiselius H (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis. https://doi.org/10.1007/s00240-015-0840-y
doi: 10.1007/s00240-015-0840-y
pubmed: 27744629
Alhamzawi R, Alhamzawi A, Mohammad Ali HT (2019) New gibbs sampling methods for bayesian regularized quantile regression. Comput Biol Med. https://doi.org/10.1016/j.compbiomed.2019.05.011
doi: 10.1016/j.compbiomed.2019.05.011
pubmed: 31125847
Meurer WJ, Tolles J (2017) Logistic regression diagnostics: understanding how well a model predicts outcomes. JAMA. https://doi.org/10.1001/jama.2016.20441
doi: 10.1001/jama.2016.20441
pubmed: 28291878
Park SY (2018) Nomogram: an analogue tool to deliver digital knowledge. J Thoracic Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2017.12.107
doi: 10.1016/j.jtcvs.2017.12.107
Ang X, Jiang Y, Cai Z, Zhou Q, Li M, Zhang B, Chen W, Chen L, Zhang X (2021) A nomogram for bladder pain syndrome/interstitial cystitis based on netrin-1. Int Urol Nephrol. https://doi.org/10.1007/s11255-021-03084-2
doi: 10.1007/s11255-021-03084-2
pubmed: 34897588
pmcid: 8831275
Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW (2018) Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. https://doi.org/10.1016/j.eururo.2018.08.038
doi: 10.1016/j.eururo.2018.08.038
pubmed: 30241973
pmcid: 6261531
Soghra R, Armin R, Jeffrey IM, Fatemeh M, Yekta R, Manouchehr N, Alireza E (2021) Ldl/apo b ratio predict coronary heart disease in type 2 diabetes independent of ascvd risk score: a case-cohort study. Nutr Metab Cardiovasc Dis. https://doi.org/10.1016/j.numecd.2021.01.013
doi: 10.1016/j.numecd.2021.01.013